Skip to content


Call for papers: Advances in Cancer Immunotherapy

Cancer ImmunotherapyWe are pleased to announce that Journal of Experimental & Clinical Cancer Research has launched a new thematic series on “Advances in Cancer Immunotherapy” to help summarize recent highlights in this field. Click here for further details on the series and for submission information.

Submission deadline: 31st May 2019

Click here to access all thematic series published to date in the Journal of Experimental & Clinical Cancer Research.

Featured article: Activities of stromal and immune cells in HPV-related cancers

New Content ItemThe mechanism for innate immune response is essential for preventing cancer development. Human papillomavirus (HPV) may cause the evasion of those mechanisms, which leads to carcinogenic host cell transformation. Therefore, immunotherapies often aim to strengthen the host's immune cells, but more recent studies have considered the importance of stromal cells (i.e. fibroblasts) in HPV-related carcinogenesis. In this review, Marconi Rego Barros Jr. et al. discuss stromal and immune cell mechanisms modulated by HPV and outline existing and potential immunotherapies targeting such mechanisms in HPV-related cancers.

Click here to access the full article. 

Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.

Aims and scope

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.

Please click here to read more.


Mauro Castelli, Regina Elena National Cancer Institute, Italy

If you would like to contact Journal of Experimental & Clinical Cancer Research, please send an email to:​​​​​​​


Most accessed articles RSS

View all articles

Celebrating the 10th anniversary partnership with BMC

JECCR 10 years​​​​​​​2018 marks the 10th anniversary of the partnership between the Journal of Experimental & Clinical Cancer Research and BMC.

Over the past decade, the journal has established itself among some of the top Oncology titles in Journal Citation Reports. Click here to look back at some of the journal’s milestone achievements and best content from the past 10 years.

2017 Impact Factor

We are delighted to share with our readers that Journal of Experimental & Clinical Cancer Research has an Impact Factor of 6.217 and is currently ranked at 33 out of 222 (Q1) in the Oncology category of Journal Citation Reports (Clarivate Analytics, 2018).

We would like to extend our appreciation to all Editorial Board Members, authors and peer reviewers who have contributed to the journal and enabled this achievement.

Archival content

Journal of Experimental & Clinical Cancer Research has been publishing since 1982.  Prior to publishing with BioMed Central from 2008, Journal of Experimental & Clinical Cancer Research was published in print.  For enquiries about previous content, please contact us on:

Reviewer Acknowledgement and New Recruitment

© Syda Productions /

The Editor-in-Chief of Journal of Experimental & Clinical Cancer Research would like to thank all of our reviewers who have contributed to the journal and is looking for new reviewers to assess manuscripts. For consideration, please send your CV with keywords and expertise to


Annual Journal Metrics